Latent membrane protein 1 Is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Geiser, Vicki ^a   Cahir McFarland, Ellen ^a   Kieff, Elliott ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; LATENT MEMBRANE PROTEIN 1; PROTEIN RTA; UNCLASSIFIED DRUG; VIRUS PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL STRAIN HEK293; DNA REPLICATION; EMBRYO; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE DELETION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS CAPSID; VIRUS RELEASE; VIRUS REPLICATION; VIRUS VIRULENCE; WILD TYPE; GENETICS; METABOLISM; PATHOGENICITY; PHYSIOLOGY; ULTRASTRUCTURE;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 4;

CAPSID; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA REPLICATION; GENE DELETION; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

EID: 80051688990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022929     Document Type: Article

References (36)

1. Rickinson AB, Kieff E, (2006) Epstein Barr Virus and its replication. In: Knipe DMH, Howley PM, editors. Fields Virology, 5th Ed Philadelphia Lippincott Williams & Wilkins pp. 2511-2574.
2. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA, (1998) EBV persistence in memory B cells in vivo. Immunity 9: 395-404.
3. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA, (1997) Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71: 4882-4891.
4. Laichalk LL, Thorley-Lawson DA, (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79: 1296-1307.
5. Shannon-Lowe C, Rowe M, (2011) Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection. PLoS Pathog 7: e1001338.
6. Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, et al. (2003) Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus. Cancer Res 63: 2982-2989.
7. Kaye KM, Izumi KM, Kieff E, (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90: 9150-9154.
8. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E, (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci U S A 97: 6055-6060.
9. Kilger E, Kieser A, Baumann M, Hammerschmidt W, (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17: 1700-1709.
10. Zimber-Strobl U, Kempkes B, Marschall G, Zeidler R, Van Kooten C, et al. (1996) Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J 15: 7070-7078.
11. Chang Y, Lee HH, Chang SS, Hsu TY, Wang PW, et al. (2004) Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J Virol 78: 13028-13036.
12. Yuan J, Cahir-McFarland E, Zhao B, Kieff E, (2006) Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol 80: 2548-2565.
13. Lu CC, Jeng YY, Tsai CH, Liu MY, Yeh SW, et al. (2006) Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 345: 358-372.
14. Webster-Cyriaque J, Middeldorp J, Raab-Traub N, (2000) Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections. J Virol 74: 7610-7618.
15. Walling DM, Ling PD, Gordadze AV, Montes-Walters M, Flaitz CM, et al. (2004) Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia. J Infect Dis 190: 396-399.
16. Webster-Cyriaque J, Raab-Traub N, (1998) Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Virology 248: 53-65.
17. Ahsan N, Kanda T, Nagashima K, Takada K, (2005) Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J Virol 79: 4415-4424.
18. Wang D, Liebowitz D, Kieff E, (1988) The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J Virol 62: 2337-2346.
19. Huen DS, Henderson SA, Croom-Carter D, Rowe M, (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10: 549-560.
20. Pich D, Humme S, Spindler MP, Schepers A, Hammerschmidt W, (2008) Conditional gene vectors regulated in cis. Nucleic Acids Res 36: e83.
21. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
22. Grueneberg DA, Degot S, Pearlberg J, Li W, Davies JE, et al. (2008) Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proc Natl Acad Sci U S A 105: 16472-16477.
23. Chen A, Zhao B, Kieff E, Aster JC, Wang F, (2006) EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 80: 10139-10150.
24. Kanno M, Fromental C, Staub A, Ruffenach F, Davidson I, et al. (1989) The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. EMBO J 8: 4205-4214.
25. Macchi M, Bornert JM, Davidson I, Kanno M, Rosales R, et al. (1989) The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines. EMBO J 8: 4215-4227.
26. Gardella T, Medveczky P, Sairenji T, Mulder C, (1984) Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J Virol 50: 248-254.
27. Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E, (2008) IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. Proc Natl Acad Sci U S A 105: 18448-18453.
28. Weitzman MD, Lilley CE, Chaurushiya MS, (2010) Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol 64: 61-81.
29. Parker BD, Bankier A, Satchwell S, Barrell B, Farrell PJ, (1990) Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179: 339-346.
30. Johnson AS, Maronian N, Vieira J, (2005) Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation. J Virol 79: 13769-13777.
31. Seifi A, Weaver EM, Whipple ME, Ikoma M, Farrenberg J, et al. (2011) The lytic activation of KSHV during keratinocyte differentiation is dependent upon a suprabasal position, the loss of integrin engagement, and calcium, but not the interaction of cadherins. Virology 410: 17-29.
32. Kutok JL, Klumpp S, Simon M, MacKey JJ, Nguyen V, et al. (2004) Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques. J Virol 78: 3455-3461.
33. Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, et al. (2007) Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 67: 1970-1978.
34. Dawson CW, Rickinson AB, Young LS, (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344: 777-780.
35. Kishimoto T, Ralph P, Good RA, (1977) Stimulation of a human B-lymphocyte line by anti-immunoglobulin and its concanavalin A-induced suppression by a T-cell line. Clin Exp Immunol 30: 62-69.
36. Chen A, Divisconte M, Jiang X, Quink C, Wang F, (2005) Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro. J Virol 79: 4506-4509.